It’s no secret that the Rare Disease Clinical Trials industry is struggling to keep operational costs under control. Between 2008 and 2013, clinical trial costs went up by a full 60%, and Tufts research indicates that the average cost of a new prescription drug approval is now more than $2.6 million. It’s worth pointing out […]